MSNATL2021

Multiple Sclerosis Nurses at the Limits 2021
Friday, 10 September – Saturday, 11 September
Post Event Videos
Optimising caseloads for MS Nurses
Professor Alison Leary
Professor of Healthcare Modelling,
London South Bank University
Real life data on newer drugs in MS
Dr Wallace Brownlee
MS Specialist Neurologist, National Hospital for Neurology and Neurosurgery; MS researcher,
Queen Square MS Centre, UCL Institute of Neurology, London
The Wellness Hub
Del Thomas
Lead Multiple Sclerosis CNS and Community Neuro CNS Team Manager,
Wye Valley NHS Trust, Hereford
MS Pregnancy register
Dr Ruth Dobson
Senior Lecturer and Honorary Consultant Neurologist; Clinical Lead for Neurology
Wolfson Institute of Preventive Neurology and Barts Health NHS Trust, London
Determining the Effectiveness of early Intensive Versus Escalation Approaches for RRMS (DELIVER-MS)
Professor Nikos Evangelou
Clinical Associate Professor,
Faculty of Medicine & Health Sciences, University of Nottingham
Do 1st line DMT’s affect the onset of secondary progression?
Dr William Brown
Department of Clinical Neurosciences,
University of Cambridge
Melanoma and the MS patient – what should MS nurses be looking for?
Professor Cris Constantinescu
Professor of Neurology,
Faculty of Medicine & Health Sciences, University of Nottingham
Functional Neurological Disorder (FND) and MS - looking for a treatable cause of disability
Professor Jon Stone
Consultant Neurologist and Honorary Professor of Neurology,
University of Edinburgh
The Lancet Lecture introduced by Dr Elena Becker-Barroso, Editor-in-Chief of The Lancet Neurology
The measurement and pathology of disease progression: How do we define secondary progression?
Professor Jeremy Hobart
Consultant Neurologist, Derriford Hospital
Professor at the Plymouth University Peninsula Schools of Medicine and Dentistry
The Nikki-Ward Abel Lecture:
The patient perspective - 8 key themes and clinical recommendations for MS nurses
Dr Therese Burke RN MSCN PhD
Clinical Co-ordinator, MS Australia; Senior Research Fellow,
School of Nursing, The University of Notre Dame, Sydney, Australia
Cannabis & MS
Dr Gillian Ingram
Consultant Neurologist, Swansea Bay University Health Board;
Honorary Senior Lecturer, Swansea University
Vaccination and MS – an overview for nurses
Professor Andrew Ustianowski
Research Lead and Consultant in Infectious Diseases & Tropical Medicine,
Manchester University NHS Foundation Trust

Support

The fixed costs of the meeting (Venue hire, AV, food & beverage, speaker fees etc.) are underwritten by Pharmaceutical Industry.